Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03078816 · ClinicalTrials.gov registry record · NA
Thalamic Deep Brain Stimulation for Secondary Dystonia in Children and Young Adults
A NA study of Dystonia, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03078816 is a NA study of Dystonia that has completed, run by University of California, San Francisco. The registered enrollment target is 5 participants, below the 540-participant average among 28 other Dystonia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03078816, a NA study of Dystonia, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
Dystonia is a movement disorder seen in both children and adults that is characterized by "sustained or intermittent muscle contractions causing abnormal, often repetitive, movements, postures, or both." Secondary dystonia is far more common in pediatric populations than primary dystonia, and far more recalcitrant to standard pharmacologic and surgical treatments including Deep Brain Stimulation (DBS). There exists a large unmet need to develop new therapeutics, treatment strategies, and outcome measures for pediatric secondary dystonia. The investigators are proposing to investigate the ventralis oralis posterior nucleus (Vop) of the thalamus as a new target for DBS in secondary dystonia. Prior to the development of DBS, the main surgical treatment of dystonia was thalamotomy. Although there were many different targets in the thalamus, often done in staged procedures, the most common and successful targeted nuclei was the Vop, which is traditionally thought to be the pallidal receiving area. Previous lesioning of Vop produced improvements in dystonia but intolerable side effects, especially when implanted bilaterally. However, given that secondary dystonia patients were often reported to have superior results to primary dystonia it is reasonable to believe that if the side effects can be modulated, that targeting of the Vop nucleus with DBS could be a viable alternative to Globus Pallidus interna (GPi). Given that Deep Brain Stimulation is a treatment that is inherently adjustable, it is conceivable that settings on the Deep Brain Stimulation could be adjusted to allow for clinical benefit with minimal side effects. Indeed, there have been several scattered successful case reports attesting to this possibility.
Conditions Studied
Interventions
- DEVICE Activa PC Primary Cell Neurostimulator - (Model 37601)
- DEVICE Activa RC Rechargeable Neurostimulator - (Model 37612)
- DEVICE Activa SC Single Cell Neurostimulator (Models 37602/37603)
- DEVICE DBS Lead - (Model 3387
- DEVICE DBS Extension - (Models 37085/6)
Study Locations (1)
California
- University of California San Francisco Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2019-07-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03078816
The ClinicalTrials.gov registry entry for NCT03078816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 540-participant average among 28 other Dystonia trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dystonia appearing as the primary indexed condition, and to 5 interventions - of which Activa PC Primary Cell Neurostimulator - (Model 37601) is the first listed.
NCT03078816 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03078816 about?
NCT03078816 is a clinical study titled "Thalamic Deep Brain Stimulation for Secondary Dystonia in Children and Young Adults". Dystonia is a movement disorder seen in both children and adults that is characterized by "sustained or intermittent muscle contractions causing abnormal, often repetitive, movements, postures, or both." Secondary dystonia is far more common in pediatric populations than primary dystonia, and far mo...
What is the current status of trial NCT03078816?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2017-03-03. Estimated completion is 2019-07-24.
What conditions does trial NCT03078816 study?
This clinical trial studies the following conditions: Dystonia.
What interventions are being tested in trial NCT03078816?
The interventions under investigation include: Activa PC Primary Cell Neurostimulator - (Model 37601) (DEVICE), Activa RC Rechargeable Neurostimulator - (Model 37612) (DEVICE), Activa SC Single Cell Neurostimulator (Models 37602/37603) (DEVICE), DBS Lead - (Model 3387 (DEVICE), DBS Extension - (Models 37085/6) (DEVICE).
Who is sponsoring clinical trial NCT03078816?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03078816 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dystonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Exercise on Dystonia Pathophysiology
RECRUITING · NA
-
Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia
RECRUITING · NA
-
Sleep-specific DBS Therapy in Parkinson's Disease
RECRUITING · NA
-
Deep Brain Stimulation Surgery for Movement Disorders
RECRUITING · NA
-
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
RECRUITING · NA
-
Cortical-Basal Ganglia Speech Networks
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.